OGEN ORAGENICS INC

NEUTRAL Impact: 6/10 DEFA14A
Horizon weeks Filed May 20, 2026 Processed 20d 9h ago SEC 0001493152-26-024605
Proxy solicitation materials
Latest settled — T+5d
OGEN ▲ +3.39% at T+5d
NEUTRAL call ✓ call won +3.39% · α vs SPY +1.54% · entry $0.5900 → $0.6100
Next anchor: T+20d in 8d
Last close $0.6000 (close Jun 8) · +1.69% from $0.5900 entry
Entry anchored
May 20, 2026
via day open
T+1d
+1.69%
call +1.69% · α +1.25%
$0.6000
settled 20d ago
T+5d
+3.39%
call +3.39% · α +1.54%
$0.6100
settled 13d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Oragenics Inc filed a DEFA14A (definitive additional proxy soliciting materials) on May 20, 2026. The filing is related to an ongoing dissident/activist proxy contest, as indicated by cross-filing context. Shareholders should expect a contested vote, likely for board seats or strategic alternatives.

Actionable Insight

Monitor for shareholder meeting date and vote outcome. The activist campaign could result in board refresh or strategic initiatives, which may be positive or negative depending on details.

Key Facts

  • Filed DEFA14A on 2026-05-20
  • Cross-filing context indicates dissident-proxy activist campaign
  • Market cap approximately $3M, highly volatile
  • No readable document content available for detailed analysis

Financial Impact

Undetermined due to lack of filing content; proxy fight could lead to significant strategic changes

governanceboard compositionpotential strategic shift

Risk Factors

  • Proposal may fail; stock could decline on unfavorable vote
  • Activist demands may not be publicly known; high uncertainty
  • Low liquidity and small cap amplify volatility

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-024605
Document: 0001493152-26-024605-index-headers.html0001493152-26-024605
Document: 0001493152-26-024605-index.html0001493152-26-024605
Document: 0001493152-26-024605.txt0001493152-26-024605
8 reports for OGEN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OGEN — sortable, filterable
Type Now
May 20, 2026
20d ago
DEFA14A
NEUTRAL ★ 6/10
$0.5900 $0.6100▲ +3.39%▲ +1.54%$0.6000 (+1.69%)
May 19, 2026
21d ago
8-K
NEUTRAL ★ 4/10
$0.5700 $0.5999▲ +5.25%▲ +3.00%$0.6000 (+5.26%)
May 7, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$0.6100 $0.5700▼ −6.56%▼ −8.06%$0.6000 (−1.64%)
Apr 13, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$0.6800 $0.7100▲ +4.41%▲ +1.12%$0.6000 (−11.76%)
Mar 25, 2026
10w ago
Press Release
BEARISH ★ 7/10
$0.5800 $0.5600▲ +3.45%▲ +5.08%$0.6000 (−3.45%)
Mar 23, 2026
11w ago
EFFECT
NEUTRAL ★ 4/10
$0.6800 $0.5000▼ −26.47%▼ −22.91%$0.6000 (−11.76%)
Mar 11, 2026
12w ago
8-K
NEUTRAL ★ 3/10
$0.9600 $0.7500▼ −21.88%▼ −20.90%$0.6000 (−37.50%)
Mar 11, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.8800 $0.7900▼ −10.23%▼ −8.04%$0.6000 (−31.82%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 7h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access